SANBR
SANT and BTB domain regulator of class switch recombination
Also known as: KIAA1841, SANBR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6NSI8
- Gene
- SANBR
- Ensembl
- ENSG00000162929
- Chromosome
- 2
- Canonical length
- 718 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable identical protein binding activity. Predicted to be involved in isotype switching. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
718 residues, UniProt reviewed canonical sequence.
>Q6NSI8|SANBR
1 MSRGYSENNN FLNNNNQMVL DMILYPLIGI PQTINWETIA RLVPGLTPKE CAKRFDELKS
61 SGSSPVDNQY NSLMAAGESP VETLATYIKS SLLDIHGEFQ ETPVGHDAVS KTGRHSIAST
121 RNCSSESENC TTHNGGEMTE ESEGPNMVIH VCDEAKNLKE DFTCPRDLLI SEMKYFAEYL
181 SMDAQRWEEV DISVHCDVHI FNWLIKYIKR NTKENKDCEM PTLEPGNVIS ILISSEFLKM
241 DSLVEQCIQY CHKNMNAIVA TPCNMNCINA NLLTRIADLF SHNEVDDLKD KKDKFKSKLF
301 CKKIERLFDP EYLNPDSRSN AATLYRCCLC KKLLTKETER RIPCIPGKIN VDRRGNIVYI
361 HIRDKTWDVH EYLNSLFEEL KSWRDVYWRL WGTINWLTCS RCYQAFLCIE FSHCQYHSET
421 VVYPTAASSL NTVGTGIYPC CNQKVLRFDP TQLTKGCKVR DHMVTLRDQG EGGDLPSCPT
481 ARMLDDLHKY RDVIVVPFSK DTVSDVGVGL CDEKGIECDV LLEPNTPWGP KTGELNAFLS
541 LKNWTLQLKQ QSLFSEEEEY TTGSEVTEDE VGDEEEVSKK QRKKEKPKKF TRQPKKQVSS
601 PCAQRKEKAL EKSASRDVSP FVMSMQKNKW DATRSLRFNQ DAQREDDQRR MTEITGHLIK
661 MRLGDLDRVK SKEAKEFAGG IYSRLEAQIK ASVPVSARQS SSEKNTRSKS RFGQGRPALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SANBR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- retina: 10 nTPM
- spinal cord: 6.7 nTPM
- cerebellum: 6.2 nTPM
- hypothalamus: 5.7 nTPM
- hippocampal formation: 4.7 nTPM
- cerebral cortex: 4.6 nTPM
Single-cell type
- retinal ganglion cells: 228 nCPM
- respiratory ciliated cells: 157 nCPM
- ependymal cells: 135 nCPM
- other brain neurons: 113 nCPM
- brain excitatory neurons: 109 nCPM
- cone photoreceptor cells: 99 nCPM
Immune cell
- eosinophil: 1.8 nTPM
- T-reg: 1.5 nTPM
- neutrophil: 1.2 nTPM
- non-classical monocyte: 1 nTPM
- intermediate monocyte: 0.7 nTPM
- classical monocyte: 0.5 nTPM
Brain region
- cerebral cortex: 16 nTPM
- white matter: 16 nTPM
- pons: 15 nTPM
- hypothalamus: 14 nTPM
- medulla oblongata: 12 nTPM
- cerebellum: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
- SANT/Myb domain
- SKP1/BTB/POZ domain superfamily
- SANT and BTB domain regulator of CSR, BTB domain
- SANBR-like
- SANT and BTB domain regulator of CSR, BTB domain
InteractionsUniProt · HPA
Protein binding partners of SANBR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SANBR as an antibody target. Whether an autoantibody or antibody against SANBR could matter depends on whether native SANBR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SANBR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SANBR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...